Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Developing non-viral DNA delivery systems for cancer and infectious disease.

Spack EG, Sorgi FL.

Drug Discov Today. 2001 Feb 1;6(4):186-197.

PMID:
11173266
2.

Recombinant viral vectors: cancer vaccines.

Harrop R, John J, Carroll MW.

Adv Drug Deliv Rev. 2006 Oct 1;58(8):931-47. Epub 2006 Aug 16. Review.

PMID:
17030074
3.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
4.

Viral-mediated gene transfer for cancer treatment.

Wilson DR.

Curr Pharm Biotechnol. 2002 Jun;3(2):151-64. Review.

PMID:
12022258
5.

[Frontier of mycobacterium research--host vs. mycobacterium].

Okada M, Shirakawa T.

Kekkaku. 2005 Sep;80(9):613-29. Japanese.

PMID:
16245793
6.

Development of herpesvirus-based episomally maintained gene delivery vectors.

Calderwood MA, White RE, Whitehouse A.

Expert Opin Biol Ther. 2004 Apr;4(4):493-505. Review.

PMID:
15102599
7.

Novel methods for the non-invasive administration of DNA therapeutics and vaccines.

van Drunen S, den Hurk LV.

Curr Drug Deliv. 2006 Jan;3(1):3-15. Review.

PMID:
16472089
8.

How not to be seen: immune-evasion strategies in gene therapy.

Zaldumbide A, Hoeben RC.

Gene Ther. 2008 Feb;15(4):239-46. Epub 2007 Nov 29. Review.

PMID:
18046427
9.

Nucleocytoplasmic transport of DNA: enhancing non-viral gene transfer.

Wagstaff KM, Jans DA.

Biochem J. 2007 Sep 1;406(2):185-202. Review.

PMID:
17680778
10.

Progress in developing cationic vectors for non-viral systemic gene therapy against cancer.

Morille M, Passirani C, Vonarbourg A, Clavreul A, Benoit JP.

Biomaterials. 2008 Aug-Sep;29(24-25):3477-96. doi: 10.1016/j.biomaterials.2008.04.036. Epub 2008 May 21. Review.

PMID:
18499247
11.

Nanoparticle based systemic gene therapy for lung cancer: molecular mechanisms and strategies to suppress nanoparticle-mediated inflammatory response.

Gopalan B, Ito I, Branch CD, Stephens C, Roth JA, Ramesh R.

Technol Cancer Res Treat. 2004 Dec;3(6):647-57.

PMID:
15560723
12.

Plasmid DNA and viral vector-based vaccines for the treatment of cancer.

Anderson RJ, Schneider J.

Vaccine. 2007 Sep 27;25 Suppl 2:B24-34. Epub 2007 Jun 6. Review.

PMID:
17698262
13.

Muscular gene transfer using nonviral vectors.

Braun S.

Curr Gene Ther. 2008 Oct;8(5):391-405. Review.

PMID:
18855634
14.

Viral gene therapy.

Mancheño-Corvo P, Martín-Duque P.

Clin Transl Oncol. 2006 Dec;8(12):858-67. Review.

PMID:
17169759
15.

Recent developments in adjuvants for vaccines against infectious diseases.

O'Hagan DT, MacKichan ML, Singh M.

Biomol Eng. 2001 Oct 15;18(3):69-85. Review.

PMID:
11566599
16.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
17.

Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.

Hatzifoti C, Roussel Y, Harris AG, Wren BW, Morrow JW, Bajaj-Elliott M.

Helicobacter. 2006 Apr;11(2):113-22.

PMID:
16579841
18.

Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems.

Brun A, Albina E, Barret T, Chapman DA, Czub M, Dixon LK, Keil GM, Klonjkowski B, Le Potier MF, Libeau G, Ortego J, Richardson J, Takamatsu HH.

Vaccine. 2008 Dec 2;26(51):6508-28. doi: 10.1016/j.vaccine.2008.09.044. Review.

PMID:
18838097
19.

The future of human gene therapy.

Rubanyi GM.

Mol Aspects Med. 2001 Jun;22(3):113-42. Review.

PMID:
11470139
20.

The mechanism of naked DNA uptake and expression.

Wolff JA, Budker V.

Adv Genet. 2005;54:3-20. Review.

PMID:
16096005
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk